Tag: poor reproducibility

Poor reproducibility in assay testing for encapsulated suspensions.

Posted on By Admin

Poor reproducibility in assay testing for encapsulated suspensions. Poor reproducibility in assay testing for encapsulated suspensions. Introduction: In the pharmaceutical industry, ensuring the quality and efficacy of drug products is paramount. Encapsulated suspensions, particularly in the form of hard and soft gelatin capsules, present unique challenges in maintaining consistent assay results. Assay testing is critical…

Read More “Poor reproducibility in assay testing for encapsulated suspensions.” »

Capsules (Hard & Soft Gelatin), Solid Oral Dosage Forms

Poor reproducibility in API release profiles over the product’s shelf life.

Posted on By Admin

Poor reproducibility in API release profiles over the product’s shelf life. Poor reproducibility in API release profiles over the product’s shelf life. Introduction: The reproducibility of Active Pharmaceutical Ingredient (API) release profiles is a critical component in the pharmaceutical industry, particularly for solid oral dosage forms such as capsules. Ensuring consistent drug release over a…

Read More “Poor reproducibility in API release profiles over the product’s shelf life.” »

Capsules (Hard & Soft Gelatin), Solid Oral Dosage Forms

Poor reproducibility in recovery rates for rinse sampling validation.

Posted on By Admin

Poor reproducibility in recovery rates for rinse sampling validation. Poor reproducibility in recovery rates for rinse sampling validation. Introduction: In the pharmaceutical industry, maintaining rigorous standards for cleanliness and contamination control is paramount. Rinse sampling validation is a critical component of this process, ensuring that manufacturing equipment is adequately cleaned between batches. However, achieving consistent…

Read More “Poor reproducibility in recovery rates for rinse sampling validation.” »

Capsules (Hard & Soft Gelatin), Solid Oral Dosage Forms